期刊文献+

化疗药物对原代胃癌细胞的体外杀伤效应及其与端粒酶逆转录酶mRNA表达的关系 被引量:10

Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA
原文传递
导出
摘要 目的观察化疗药物对原代胃癌细胞的体外杀伤效应,并探讨其与胃癌组织中端粒酶逆转录酶(hTERT)mRNA表达的关系。方法将68例新鲜胃癌组织制备单细胞悬液,台盼蓝染色计数活细胞,分别加入紫杉醇(TZX)、阿霉素(ADM)、顺铂(CDDP)、5-氟尿嘧啶(5-Fu)和丝裂霉素(MMC)培养48 h。四甲基偶氮唑盐(MTT)法观察药物作用后肿瘤细胞活力及代谢活性变化。用原位杂交技术检测hTERT mRNA的表达。结果不同个体的肿瘤细胞对化疗药物敏感性不同,与肿瘤分化有关,TAX、CDDP、5-Fu、ADM和MMC的胃癌细胞抑制率分别为(40.6±6.9)%、(38.4±7.8)%、(38.9±9.2)%、(31.6±8.5)%和(28.9±9.8)%。全组hTERT mRNA表达阳性率为90.0%,hTERT mRNA阳性者对5-Fu和ADM有较强的耐药性。结论hTERT mRNA的高表达可能是胃癌原发性耐药的标志之一,MTT比色法体外药敏实验有助于筛选胃癌的个体化有效化疗药物。 Objective To evaluate in vitro antitumor effects of chemotherapeutic drugs, and investgate the relationship with expression of hTERT mRNA in human gastric cancer tissues. Methods Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 × 10^5 to 5 × 10^5 cells ml^-1) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5- Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours. Metabolic activity and inhibitory rate of the cells were determined by trypan blue exclusion and MTT assay. Expression of hTERT mRNA was detected by in situ hybridization (ISH). Results The inhibition rate of cancer cells exposed to chemotherapeutic drugs was different, and that of TAX, CDDP, 5-Fu was significantly higher than that of ADM and MMC. The positive rate of hTERT mRNA expression was 90.0% (54/60) and positive cells showed resistance to 5-Fu and ADM. Conclusion Overexpression of hTERT mRNA may contribute to primary drug-resistance of tumors. Chemosensitivity tests by MTT assay may contribute to prediction of effectness in applying chemotherapeutic drugs and identify drug-resistant cases.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2007年第11期838-841,共4页 Chinese Journal of Oncology
关键词 胃肿瘤 HTERT mRNA 化疗药物敏感性 Stomach neoplasms hTERT mRNA Chemosensitivity
  • 相关文献

参考文献8

二级参考文献33

  • 1Blanc E, Goldschneider D, Ferrandis E, et al. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model [J]. Am J Pathol, 2003, 163(1):321-331.
  • 2Latil A,Vidaud D,Valeri A, et al. hTERT expression correlates with MYC over-expression in human prostate cancer [J]. Int J Cancer, 2000, 89(2) : 172-176.
  • 3Haber M, Bordow SB, Gilberi J, et al. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells [J]. Oncogene, 1999, 18(17): 2777-2782.
  • 4Iczkowski KA, Huang W, Mazzucchelli R, et al. Androgen ablation therapy for prostate carcinoma suppresses the immunoreative telomerase subunit hTERT [J]. Cancer, 2004, 100 (2) : 294-299.
  • 5Thomas GA, Barrand MA, Stewart S, et al. Expression of the muhidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridization [J]. Eur J Cancer, 1994, 30A (11): 1705-1709.
  • 6Wu TC, Lin P, Hsu CP, et al. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas [J]. Lung Cancer, 2003, 41(2) : 163-169.
  • 7Lantuejoul S, Sofia JC, Moro-Sibilot D, et al. Differelltial expression of telomerase reverse trallscriptase (hTERT) in lung tumours [J]. Br J Cancer, 2004, 90(6): 1222-1229.
  • 8Kuranaga N, Shinomiya N, Mochizuki H, et al. Long-term cultivation of colorectal carcinoma cells with anti-cancer drugs induces drug resistance and telonlcrc elongation: an in ritro study [J]. BMC Cancer, 2001, 1(1):10-17.
  • 9Blanc E, Goldschneider D, Ferrandis E, et al. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model [J]. Am J Pathol,2003, 163(1):321-331.
  • 10Latil A,Vidaud D,Valeri A, et al. hTERT expression correlates with MYC over-expression in human prostate cancer [J]. Iht J Cancer, 2000, 89(2): 172-176.

共引文献31

同被引文献91

引证文献10

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部